70 completed, 21 unknown, 17 recruiting, 12 terminated. 85 Not applicable, 20 Phase 2, 8 Phase 3, 4 Phase 1, 3 Early Phase 1.
Follow Hallucinations: new trials by email Literature Review of Hallucinations trials Research Report on Hallucinations
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing a Peer-Support Group for Veterans Who Hear Voices Veteran Voices and Visions (VVV), Wellness Recovery Action Planning (WRAP) - Psychotic Disorders, Hallucinations, Auditory | Not applicable | Not yet recruiting | VA Office of Research and Development | 160 | 2027-04-01 | 2026-04-29 |
| LIFU Effects & Outcomes: Mechanisms Evaluating Striatal Systems Imaging (LEO MESSI) LIFU - Schizophrenia, Auditory Hallucinations | Not applicable | Not yet recruiting | University of California, San Francisco | 12 | 2027-02-01 | 2026-08-05 |
| DecNef for Auditory Verbal Hallucinations (AVH) in Schizophrenia Decoded Neurofeedback - Schizophrenia Disorder, Schizoaffecitve Disorder | Not applicable | Not yet recruiting | Columbia University | 51 | 2026-12-01 | 2026-10-14 |
| Visual Hallucinations in Lewy Body Diseases Behavioral Tasks, MRI/MEG Scans - Lewy Body Disease, Lewy Body Dementia | Recruiting | NYU Langone Health | 234 | 2026-09-15 | 2026-09-30 | |
| Impact of EDEN College Courses on the Quality of Life of Voice-Hearers EDEN College, TAU - Hallucinations, Auditory | Not applicable | Recruiting | Hôpital le Vinatier | 240 | 2026-09-08 | 2026-09-11 |
| Building a Computational Model of Auditory Hallucinations Schizophrenia / Schizoaffective Disorder, Schizophrenia and Disorders With Psychotic Feature | Not yet recruiting | King's College London | 146 | 2026-09-01 | 2026-09-15 | |
| Neuronavigated rTMS for Treatment-Resistant Auditory Hallucinations Neuronavigated repetitive transcranial magnetic stimulation (rTMS), Sham repetitive transcranial magnetic stimulation (rTMS) - Schizophrenia, Auditory Verbal Hallucinations | Not applicable | Recruiting | Psychiatric University Hospital, Zurich | 40 | 2026-06-11 | 2026-10-02 |
| The ECHO Study: Compassion-focused Therapy for Young Voice Hearers and Their Caregivers ECHO Manualized CFT treatment for young voice heares - Hallucinations, Auditory | Not applicable | Not yet recruiting | University of Southern Denmark | 80 | 2026-06-01 | 2026-02-24 |
| The Role of Priors in Hallucinatory Perception in Parkinson's Disease PARKINSON DISEASE (Disorder) | Recruiting | University Hospital, Grenoble | 60 | 2026-04-28 | 2026-09-30 | |
| An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis ML-007C-MA - Psychosis Associated With Alzheimer's Disease | Phase 2 | Enrolling by invitation | MapLight Therapeutics | 210 | 2026-03-25 | 2026-08-07 |
| Validation of a VOICE MAnagement Program in Schizophrenia VVoice MAPS Integrative group therapy - Mental Disorder, Schizophrenia Diagnosis | Not applicable | Not yet recruiting | Centre Hospitalier Universitaire de la Guadeloupe | 116 | 2026-01-05 | 2025-12-05 |
| Effect of Cognitive Behavioral Therapy on Auditory Hallucinations and NLR in Schizophrenia Patients Cognitive Behavioral Therapy (CBT), risperidone - Schizophrenia Patients, Auditory Hallucination | Not applicable | Completed | Hasanuddin University | 50 | 2025-11-01 | 2026-04-17 |
| Role of Inferior Colliculi in Auditory Hallucinations Unenhanced brain MRI - Schizophrenia, Hallucinations, Auditory | Not applicable | Recruiting | Centre Hospitalier Universitaire de Nīmes | 40 | 2025-09-12 | 2025-12-09 |
| A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis ML-007C-MA, Placebo - Psychosis Associated With Alzheimer's Disease | Phase 2 | Recruiting | MapLight Therapeutics | 300 | 2025-08-15 | 2026-09-30 |
| Cost-utility Study of Cognitive-behavioral Management of Auditory Hallucinations in Schizophrenic Disorder Cognitive and behavioral therapy for auditory hallucinations, Usual treatment - Auditory Hallucinations, Schizophrenia Spectrum | Not applicable | Not yet recruiting | University Hospital, Montpellier | 240 | 2025-08-01 | 2025-08-21 |
| A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017 LY03017, LY03017-Placebo - Hallucinations and Delusions Associated With Alzheimer's Disease Psychosis, Hallucinations and Delusions Associated With Parkinson Disease Psychosis | Phase 1 | Not yet recruiting | Luye Pharma Group Ltd. | 40 | 2025-05-01 | 2025-05-20 |
| The Effectiveness of Combining AR/VR Technology in Virtual Clinical Auditory Hallucinations on the Comprehensive Auditory Hallucination Nursing Competency of Psychiatric Nurses Virtual clinical auditory hallucination solution combining AR/VR technology, Auditory Hallucination Care Video - Nurses, Schizophenia Disorder | Not applicable | Not yet recruiting | National Yang Ming Chiao Tung University | 200 | 2025-05-01 | 2025-05-08 |
| RTMS for Refractory Auditory Hallucinations Based on Personalized Targets Using Magnetoencephalography rTMS - Refractory Auditory Hallucinations, Schizophrenia | Not applicable | Recruiting | Shanghai Mental Health Center | 36 | 2025-02-05 | 2025-02-14 |
| Charles Bonnet Syndrome in Low Vision Patients Charles Bonnet Syndrome | Enrolling by invitation | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 640 | 2025-01-15 | 2026-05-01 | |
| Neuro-VR: Augmenting a Virtual Reality-based Therapy With Biofeedback for Auditory Hallucinations Virtual Reality-based Intervention employing Neurofeedback, Virtual Reality-based Intervention - Auditory Hallucinations, Schizophrenia | Not applicable | Active not recruiting | University Hospital Bispebjerg and Frederiksberg | 30 | 2024-11-12 | 2026-05-06 |
Showing 20 of 136. Sign in to see all of them.
Schizophrenia (79) · Psychotic Disorders (44) · Delusions (17) · Parkinson Disease (12) · Alzheimer Disease (7) · Dementia (7) · Mental Disorders (7) · Schizophrenia, Treatment-Resistant (7) · Lewy Body Disease (5) · Charles Bonnet Syndrome (4) · Schizophrenia Spectrum and Other Psychotic Disorders (4) · Dissociative Disorders (3) · Paranoid Disorders (3) · Brain Diseases (2)
Neurobehavioral Manifestations (136) · Neurologic Manifestations (136) · Pathological Conditions, Signs and Symptoms (136) · Signs and Symptoms (136) · Perceptual Disorders (135) · Nervous System Diseases (134) · Mental Disorders (98) · Schizophrenia Spectrum and Other Psychotic Disorders (93) · Brain Diseases (22) · Central Nervous System Diseases (22) · Behavior (21) · Neurodegenerative Diseases (20) · Basal Ganglia Diseases (17) · Behavioral Symptoms (17) · Movement Disorders (17)
Transcranial Direct Current Stimulation (12) · Transcranial Magnetic Stimulation (12) · Cognitive Behavioral Therapy (9) · Therapeutics (7) · pimavanserin (5) · Risperidone (3) · Quetiapine Fumarate (2) · Vision, Ocular (2) · nelotanserin (2) · 3-(6-p-tolylpyridin-3-yloxy)-1-azabicyclo(2.2.2)octane (1) · Antipsychotic Agents (1) · Apomorphine (1) · Behavior Therapy (1) · Citalopram (1) · Donepezil (1)
Yale University (8) · ACADIA Pharmaceuticals Inc. (5) · Hôpital le Vinatier (4) · Ciusss de L'Est de l'Île de Montréal (3) · Columbia University (3) · University Hospital, Caen (3) · University of North Carolina, Chapel Hill (3) · Assistance Publique - Hôpitaux de Paris (2) · Axovant Sciences Ltd. (2) · Charite University, Berlin, Germany (2) · Luye Pharma Group Ltd. (2) · MapLight Therapeutics (2) · National Institute of Mental Health (NIMH) (2) · New York State Psychiatric Institute (2) · Novartis Pharmaceuticals (2)
United States (51) · France (25) · Germany (9) · Netherlands (7) · Spain (7) · Switzerland (7) · Canada (6) · United Kingdom (6) · Bulgaria (5) · China (5) · Italy (5) · South Korea (5) · Brazil (4) · Chile (4) · Czechia (4)
Flavio Frohlich, PhD (3) · Philip R Corlett, PhD (3) · Alexandre Dumais, MD, Ph.D (2) · Ilise Lombardo, MD (2) · Ippolytos A Kalofonos, MD PhD MPH (2) · Michael Avissar, MD, PhD (2) · Olaf Blanke (2) · Sonia Dollfus, MD, PhD (2) · Adam Anderson, Ph.D. (1) · Albert Powers, MD, PhD (1) · Alexandre Dumais, MD, PhD (1) · Alice Cronin-Golomb, PhD (1) · Amardeep Singh, MD, PhD (1)
PMID 11040883, PMID 12802165, PMID 15936729, PMID 17035647, PMID 17984395, PMID 18442107, PMID 18519523, PMID 18591063, PMID 19348793, PMID 19369318, PMID 19524477, PMID 19740486, PMID 20214847, PMID 20962287, PMID 21436683, PMID 21584907, PMID 21921019, PMID 22410480, PMID 22581236, PMID 2280326, PMID 23485015, PMID 23882203, PMID 23934921, PMID 25382161, PMID 25733569, PMID 26474316, PMID 26709292, PMID 27249781, PMID 27714429, PMID 28197931, PMID 28215900, PMID 28375205, PMID 28660668, PMID 28979730, PMID 29045769, PMID 29175276, PMID 29224040, PMID 29496306, PMID 29653532, PMID 29859917, PMID 29897597, PMID 30050047, PMID 30124303, PMID 30535067, PMID 32074412, PMID 32308631, PMID 32790453, PMID 32914542, PMID 33176899, PMID 33558239
R01MH073673 (3), K23MH119318 (2), R01MH067073 (2), 2017 (1), 2025 (1), K23MH077653 (1), N01MH090001 (1), N01MH90001 (1), R01AG047146 (1), R01NS148898 (1), R21MH063326 (1), R21MH105574 (1), R21MH116258 (1), R21MH122940 (1), R21MH128823 (1)